100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Class notes

Lecture notes Year 1 MBChB: Introduction to Medical Sciences (IMS)

Rating
4.0
(1)
Sold
1
Pages
8
Uploaded on
03-01-2021
Written in
2017/2018

Concise lecture notes from the pharmacology strand of the IMS module taught in the first year of the MBChB course at the University of Leeds!

Institution
Course









Whoops! We can’t load your doc right now. Try again or contact support.

Connected book

Written for

Institution
Study
Course

Document information

Uploaded on
January 3, 2021
Number of pages
8
Written in
2017/2018
Type
Class notes
Professor(s)
Mbchb year 1: introduction to medical science
Contains
All classes

Subjects

Content preview

PHARMOCOGOLY


PHARMACOKINETICS


What is pharmacology? - effect of chemicals on biological entities
 Study of drugs: the way drugs react biologically at receptor sites
 Study of drug effects: effect the drug has when taken by a person
 Considers therapeutic and toxic effects

Drug: a natural product, chemical substance or pharmaceutical preparation intended for administration to a human or
animal to diagnose or treat a disease

What is a medical device?
 Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or
other similar article, intended for the specific medical purposes of:
o Diagnosis, prevention, monitoring, treatment or alleviation of disease/injury
o Control of conception, disinfection of medical devices

Drug names
 Generic name- approved or official name
 Trade or brand name- name given to drug by its pharmaceutical company
 Chemical name- dependent on the drugs chemical structure
 Use name- use for which they are prescribed, anti-inflammatories
 Effect name- the physiological or biological response in the body

Route Advantage Disadvantage
ORAL Convenient, safe, economical Cannot be used for that are inactivated by 1st
pass metabolism or that irritate the gut
INTRAMUSCULAR Suitable for suspensions and oily substances May be painful
Rapid absorption from solutions May cause bleeding at site of injection
Slow and sustained absorption from suspensions
SUBCUTANEOUS Suitable for suspensions and pellets Cannot be used to deliver large volumes of fluid
Under the skin Cannot be used for drugs that irritate cutaneous
tissue
INTRAVENOUS Bypasses absorption, causes immediate effect May be painful
100% immediate bioavailability May cause bleeding at site of injection
BUCCAL Rapidly absorbed Effective only for low doses
Avoids 1st pass metabolism Drugs must be water and lipid soluble
TRANSDERMAL Avoids 1st pass metabolism Effective only for low doses of drug that are
Through the skin highly lipid soluble
into bloodstream
INHALATIONAL Produce a localised effect Drug particles must be correct size
Dependent on patient technique
EPIDURAL Provides a targeted effect Risk of failure
Epidural space of Risk of infection
the spinal cord
TOPICAL Non-invasive and easy to administer Poorly lipid soluble not absorbed via skin or
Applying to the mucous membranes
body surfaces Very slow absorption

Types of oral preparations
Tablet Compressed powder
Can be coated - protection against environment or mask unpleasant taste or protect against stomach acid
Capsule Solid dosage forms containing drug and fillers enclosed in a soft or hard gelatine shell
Solution Active constituents (solute) is dissolved in a solvent
Suspension Finely divided drug suspended in a suitable vehicle
Useful method of administering large amounts of drug

, Using modified dose forms
Advantages Disadvantages
Improved patient adherence Cost more per unit dose than conventional forms
Reduction in incidence and severity of GIT effects Possibility of unsafe over dosage if used incorrectly of in
failure of MR tablet
Improved control over therapeutic plasma Rate of transit through GIT limits the maximum period for
concentrations which a therapeutic response can be maintained
 Maintenance of therapeutic action overnight Variability in physiological factors
 Minimise adverse effects associated with high
plasma concentrations

PHARMACOKINETICS – how drugs are absorbed in body, distributed, metabolised and eliminated
Absorption
 Transfer of the drug from the site of administration into the general or systemic circulation
 Absorption from the gut or other routes
 Oral absorption (approx. 75% of drug absorbed orally in 1-3hrs)

Factors affecting oral absorption:
 Particle size and formulation, GIT enzymes/Acid
 GIT motility
 Physicochemical factors
 Food

pH and drug absorption
 Drugs are either acids or bases
 In water, strong acids and bases are 100% ionised
 Increasing pH: acids become increasingly ionised and bases become increasingly unionised
 The lipophilic nature of the cell membrane only permits the passage of the uncharged fraction

Distribution
 The process by which the drug is transferred reversibly
o from the general circulation  tissues as concentrations in blood increase
o from the tissues  blood as concentrations in blood decrease
 Mainly occurs by passive diffusion of un-ionised form across the cell membrane
 After IV injection
o High plasma concentration and drug rapidly equilibrates with well-perfused tissue giving relatively high
concentrations
Drug movement
 Bulk flow transfer – blood transfer
 Diffusion transfer – molecule by molecule – short distances
 Drugs can cross cellular barriers by:
o Passive diffusion transfer – only if drug is lipid soluble
o Carrier mediated transfer

Volume of distribution
 VoD- size of a compartment that accounts for the total amount of drug in the body based on the amount in the
plasma at time zero
 Used to determine the loading dose necessary for a desired blood concentration of a drug
 Used for estimating a blood concentration in the treatment of overdose
 Large VoD- requires a larger dose for a set conc in the blood

Factors affecting drug distribution
 Plasma protein binding, specific drug receptor sites, regional blood flow, lipid solubility, disease

Drug-protein binding
 Drug + Protein ↔ Drug – protein complex
 Binding of drugs with albumin and glycoproteins
 Reversible structure
 Albumin bound: Furosemide, ibuprofen, phenytoin, thiazides, warfarin
 Glycoprotein bound: chlorpromazine, propranolol, tricyclic antidepressants, lidocaine
 Administration of a drug that becomes highly protein bound to a patient who is already taking a drug that is highly
protein bound:
$10.32
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached


Document also available in package deal

Reviews from verified buyers

Showing all reviews
3 months ago

good

4.0

1 reviews

5
0
4
1
3
0
2
0
1
0
Trustworthy reviews on Stuvia

All reviews are made by real Stuvia users after verified purchases.

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
azreenafzal University of Leeds
Follow You need to be logged in order to follow users or courses
Sold
20
Member since
4 year
Number of followers
8
Documents
16
Last sold
4 months ago

4.1

11 reviews

5
1
4
10
3
0
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can immediately select a different document that better matches what you need.

Pay how you prefer, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card or EFT and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions